These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25543683)

  • 1. 3D-QSAR studies on Plasmodium falciparam proteins: a mini-review.
    Divakar S; Hariharan S
    Comb Chem High Throughput Screen; 2015; 18(2):188-98. PubMed ID: 25543683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
    Neves BJ; Bueno RV; Braga RC; Andrade CH
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
    Shah P; Siddiqi MI
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring clotrimazole-based pharmacophore: 3D-QSAR studies and synthesis of novel antiplasmodial agents.
    Brogi S; Brindisi M; Joshi BP; Sanna Coccone S; Parapini S; Basilico N; Novellino E; Campiani G; Gemma S; Butini S
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5412-8. PubMed ID: 26428874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
    Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening.
    Zhang L; Fourches D; Sedykh A; Zhu H; Golbraikh A; Ekins S; Clark J; Connelly MC; Sigal M; Hodges D; Guiguemde A; Guy RK; Tropsha A
    J Chem Inf Model; 2013 Feb; 53(2):475-92. PubMed ID: 23252936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
    Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
    Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.
    Dali B; Keita M; Megnassan E; Frecer V; Miertus S
    Chem Biol Drug Des; 2012 Apr; 79(4):411-30. PubMed ID: 22129033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-drug interaction studies for development of drugs against Plasmodium falciparum.
    de Azevedo WF; Caceres RA; Pauli I; Timmers LF; Barcellos GB; Rocha KB; Soares MB
    Curr Drug Targets; 2009 Mar; 10(3):271-8. PubMed ID: 19275563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.
    Qidwai T; Khan F
    Chem Biol Drug Des; 2012 Aug; 80(2):155-72. PubMed ID: 22487082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in silico strategy for identification of novel drug targets against Plasmodium falciparum.
    Rout S; Patra NP; Mahapatra RK
    Parasitol Res; 2017 Sep; 116(9):2539-2559. PubMed ID: 28755265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors.
    Tseng TS; Lee YC; Hsiao NW; Liu YR; Tsai KC
    Bioorg Med Chem Lett; 2016 Jan; 26(2):265-271. PubMed ID: 26707392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D-QSAR Modeling and Synthesis of New Fusidic Acid Derivatives as Antiplasmodial Agents.
    Kaur G; Pavadai E; Wittlin S; Chibale K
    J Chem Inf Model; 2018 Aug; 58(8):1553-1560. PubMed ID: 30040885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the structural requirements in multiple chemical scaffolds for the selective inhibition of Plasmodium falciparum calcium-dependent protein kinase-1 (PfCDPK-1) by 3D-pharmacophore modelling, and docking studies.
    Aher RB; Roy K
    SAR QSAR Environ Res; 2017 May; 28(5):390-414. PubMed ID: 28562086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening.
    Batool S; Khan ZA; Kamal W; Mushtaq G; Kamal MA
    Med Chem; 2015; 11(7):687-700. PubMed ID: 25741881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.
    Parenti MD; Pacchioni S; Ferrari AM; Rastelli G
    J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium kinases as targets for new-generation antimalarials.
    Lucet IS; Tobin A; Drewry D; Wilks AF; Doerig C
    Future Med Chem; 2012 Dec; 4(18):2295-310. PubMed ID: 23234552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.